Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Eugenia Quiros-Roldan

Showing results (201-210 of 209) with videos related to

Pageof 21
Sort By:
You have reached the last page of results.This site can display upto 209 results.
International Journal of Cancer|June 20, 2019
Cervical cancer risk in women living with HIV across four continents: A multicohort studyEliane Rohner, Lukas Bütikofer, Kurt Schmidlin, et al.
Heliyon|September 9, 2024
Monoclonal antibodies against SARS-CoV-2 to prevent COVID-19 worsening in a large multicenter cohortAlessandro Soria, Francesca Graziano, Giulia Ghilardi, et al.
JCI Insight|November 24, 2020
An immune-based biomarker signature is associated with mortality in COVID-19 patientsMichael S Abers, Ottavia M Delmonte, Emily E Ricotta, et al.
The New England Journal of Medicine|April 11, 2020
Compassionate Use of Remdesivir for Patients with Severe Covid-19Jonathan Grein, Norio Ohmagari, Daniel Shin, et al.
Medrxiv : the Preprint Server for Health Sciences|August 15, 2020
Magnitude and Dynamics of the T-Cell Response to SARS-CoV-2 Infection at Both Individual and Population LevelsThomas M Snyder, Rachel M Gittelman, Mark Klinger, et al.
The Journal of Allergy and Clinical Immunology|December 28, 2023
Perturbations of the T-cell receptor repertoire in response to SARS-CoV-2 in immunocompetent and immunocompromised individualsOttavia M Delmonte, Cihan Oguz, Kerry Dobbs, et al.
Frontiers in Immunology|January 22, 2025
Magnitude and dynamics of the T-cell response to SARS-CoV-2 infection at both individual and population levelsThomas M Snyder, Rachel M Gittelman, Mark Klinger, et al.
Science (New York, N.Y.)|September 25, 2020
Autoantibodies against type I IFNs in patients with life-threatening COVID-19Paul Bastard, Lindsey B Rosen, Qian Zhang, et al.
Science (New York, N.Y.)|September 25, 2020
Inborn errors of type I IFN immunity in patients with life-threatening COVID-19Qian Zhang, Paul Bastard, Zhiyong Liu, et al.
Pageof 21

Showing results (201-210 of 209) with videos related to

Sort By:
Pageof 21
You have reached the last page of results.This site can display upto 209 results.
International Journal of Cancer|June 20, 2019
Cervical cancer risk in women living with HIV across four continents: A multicohort studyEliane Rohner, Lukas Bütikofer, Kurt Schmidlin, et al.
Heliyon|September 9, 2024
Monoclonal antibodies against SARS-CoV-2 to prevent COVID-19 worsening in a large multicenter cohortAlessandro Soria, Francesca Graziano, Giulia Ghilardi, et al.
JCI Insight|November 24, 2020
An immune-based biomarker signature is associated with mortality in COVID-19 patientsMichael S Abers, Ottavia M Delmonte, Emily E Ricotta, et al.
The New England Journal of Medicine|April 11, 2020
Compassionate Use of Remdesivir for Patients with Severe Covid-19Jonathan Grein, Norio Ohmagari, Daniel Shin, et al.
Medrxiv : the Preprint Server for Health Sciences|August 15, 2020
Magnitude and Dynamics of the T-Cell Response to SARS-CoV-2 Infection at Both Individual and Population LevelsThomas M Snyder, Rachel M Gittelman, Mark Klinger, et al.
The Journal of Allergy and Clinical Immunology|December 28, 2023
Perturbations of the T-cell receptor repertoire in response to SARS-CoV-2 in immunocompetent and immunocompromised individualsOttavia M Delmonte, Cihan Oguz, Kerry Dobbs, et al.
Frontiers in Immunology|January 22, 2025
Magnitude and dynamics of the T-cell response to SARS-CoV-2 infection at both individual and population levelsThomas M Snyder, Rachel M Gittelman, Mark Klinger, et al.
Science (New York, N.Y.)|September 25, 2020
Autoantibodies against type I IFNs in patients with life-threatening COVID-19Paul Bastard, Lindsey B Rosen, Qian Zhang, et al.
Science (New York, N.Y.)|September 25, 2020
Inborn errors of type I IFN immunity in patients with life-threatening COVID-19Qian Zhang, Paul Bastard, Zhiyong Liu, et al.
Pageof 21